Manufacturing News and Research

RSS
Elan 2010 total revenue increases 5% to $1,169.7 million

Elan 2010 total revenue increases 5% to $1,169.7 million

NKT, DSM sign contract to develop therapeutics based on natural killer T cells

NKT, DSM sign contract to develop therapeutics based on natural killer T cells

Almac opens analytical facility at new 240,000 sq. ft. North American Headquarters

Almac opens analytical facility at new 240,000 sq. ft. North American Headquarters

Breakthrough in Thermal Gradient's fast PCR technology for molecular diagnostics

Breakthrough in Thermal Gradient's fast PCR technology for molecular diagnostics

Helix Medical to invest over $4M for new manufacturing facility in Costa Rica

Helix Medical to invest over $4M for new manufacturing facility in Costa Rica

Progenics, Salix enter exclusive worldwide license agreement for RELISTOR

Progenics, Salix enter exclusive worldwide license agreement for RELISTOR

AMRI fourth quarter total revenue increases 12% to $48.6 million

AMRI fourth quarter total revenue increases 12% to $48.6 million

Lotus adds two additional stories to new Beijing headquarters building

Lotus adds two additional stories to new Beijing headquarters building

Roche launches cobas TaqScreen DPX Test for parvovirus B19 and hepatitis A virus

Roche launches cobas TaqScreen DPX Test for parvovirus B19 and hepatitis A virus

Onset Therapeutics announces corporate name change to Onset Dermatologics

Onset Therapeutics announces corporate name change to Onset Dermatologics

FDA approves ANDA for phentermine HCl 37.5 mg tablets

FDA approves ANDA for phentermine HCl 37.5 mg tablets

BIOTRONIK launches Reliaty pacing system analyzer in Europe

BIOTRONIK launches Reliaty pacing system analyzer in Europe

AMRI's Burlington facility granted AIFA approval to manufacture octreotide

AMRI's Burlington facility granted AIFA approval to manufacture octreotide

Nitto Denko announces acquisition of Avecia Biotechnology

Nitto Denko announces acquisition of Avecia Biotechnology

Researchers develop hard X-ray laser to determine structure of biomolecules

Researchers develop hard X-ray laser to determine structure of biomolecules

Seattle Genetics prices underwritten public offering of 10,000,000 shares of common stock

Seattle Genetics prices underwritten public offering of 10,000,000 shares of common stock

Aphios enters subcontract with SAIC-Frederick to develop phospholipid nanoencapsulated camptothecin

Aphios enters subcontract with SAIC-Frederick to develop phospholipid nanoencapsulated camptothecin

FDA to inspect Lannett's manufacturing facility for review of Morphine Sulfate NDA

FDA to inspect Lannett's manufacturing facility for review of Morphine Sulfate NDA

Genzyme's diagnostic products sold to Sekisui Chemical for $265 million

Genzyme's diagnostic products sold to Sekisui Chemical for $265 million

Positive interim results from H5N1 Avian Influenza VLP vaccine Phase II human clinical trial

Positive interim results from H5N1 Avian Influenza VLP vaccine Phase II human clinical trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.